August 16, 2023
Inc. 5000 Named Gestalt No. 3835 Among America’s Fastest-Growing Private Companies
“Gestalt Ranked 223rd in the Healthcare Services Sector.”
August 15, 2023 – Spokane, WA. –– Inc. revealed that Gestalt Diagnostics, a leading provider of artificial intelligence (AI) powered digital pathology solutions, ranks No. 3835 on the 2023 Inc. 5000 list, the most prestigious ranking of the fastest-growing private companies in America. In addition to this honorable rank, Gestalt Diagnostics is the 223rd fastest-growing private company in the healthcare services sector. The list represents a unique look at the country’s most successful private businesses and is a key benchmark for entrepreneurial success.
“We are honored and proud to be ranked as the 3835th fastest-growing private company in the US by Inc.,” stated Dan Roark, CEO of Gestalt. “The dedication, commitment, and success of our team, solutions, and customers is exemplified in the attainment of this achievement. Gestalt’s unwavering commitment to advancing the adoption of innovative, industry-leading solutions to provide better cancer healthcare and precision medicine is essential to improving patient outcomes and ultimately making a meaningful difference in the lives of patients and their families.”
This recognition serves as a resounding validation of the remarkable strides made by Gestalt in enabling better patient care and furthering drug discovery through innovative digital solutions.
“Running a business has only gotten harder since the end of the pandemic,” says Inc. editor-in-chief Scott Omelianuk. “To make the Inc. 5000—with the fast growth that it requires—is truly an accomplishment. Inc. is thrilled to honor the companies that are building our future.”
Gestalt’s inclusion on the Inc. 5000 list comes at a significant time of growth for the company, through its digital solution PathFlow® over 280 pathologists are diagnosing over 90,000 cases, with 5% diagnosed utilizing leading-edge AI algorithms with formidable computational capabilities, managing over 2,800,000 images. Today, PathFlow® enables pathologists to provide faster and more accurate diagnoses* resulting in improved patient care and pathologist experience.
About Inc. and the Inc. 5000
Companies on the 2022 Inc. 5000 are ranked according to percentage revenue growth from 2019 to 2022. They must be U.S.-based, privately held, for-profit, and independent as of December 31, 2022. The minimum revenue required for 2019 is $100,000; the minimum for 2022 is $2 million Inc. Business Media is the leading multimedia brand for entrepreneurs. Inc.’s proprietary Inc. 5000 list, analyzes company data to rank the fastest-growing privately held businesses in the United States. To learn more, visit http://www.inc.com/inc5000.
*Research Use Only (RUO) unless following CAP guidelines for LDT. CE-certified per in vitro diagnostic Medical Device Directive 98/79/EEC.
SOURCE: Gestalt
© 2023 Tissuepathology.com. All rights reserved. Millennial Consulting. | Web Design by Zealth Digital Marketing